远端帽辅助EMR可安全有效切除炎症性肠病背景下粘连性异型增生病变:一项多中心回顾性研究(附视频)
本研究回顾性评估16例炎症性肠病患者,采用远端帽辅助EMR(EMR-DC)切除因黏膜下纤维化导致负抬举征的粘连性结肠异型增生病变,75%的患者实现完全切除且术后30天内无严重不良事件,作者认为EMR-DC是有效、安全且经济的选择。
要点
- EMR-DC用于炎症性肠病伴黏膜下纤维化的粘连性异型增生病变。
- 75%的患者实现完全切除,术后30天内无严重不良事件。
- 作者认为EMR-DC有效、安全且经济。
核心结论
- EMR-DC是切除慢性炎症性肠病中粘连性异型增生病变的有吸引力的选择,有效、安全且经济。
研究设计与样本
- 多中心回顾性研究,从2个高容量中心回顾性评估16例炎症性肠病患者。
主要发现
- 75%接受EMR-DC治疗的患者实现完全切除,术后30天内无严重不良事件。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: EMR is established as the primary approach for large and complex dysplastic lesions. However, submucosal fibrosis caused by previous attempts at removal, biopsy sampling, inflammation, or tattoo placement can cause a benign "negative lift sign" and create difficulty for EMR. Here, we present the use of distal cap-assisted EMR (EMR-DC) specifically for the use of resecting dysplastic colonic lesions when submucosal fibrosis is present in patients with inflammatory bowel disease (IBD). METHODS: Sixteen IBD patients were retrospectively evaluated from 2 high-volume centers. Patient demographics, lesion pathology and classification, outcomes including time and success of resection, serious adverse events (SAEs) within 30 days of the procedure, and efficacy were measured. RESULTS: Seventy-five percent of patients treated with EMR-DC achieved complete resection with no SAEs within 30 days of the procedure. CONCLUSIONS: EMR-DC represents an attractive option for the resection of adherent, dysplastic lesions in chronic IBD that is effective, safe, and inexpensive.
引用
- Moyer MT, Leisgang AR, Kelly M, et al. Distal cap-assisted EMR allows the safe and effective resection of adherent dysplastic lesions in the setting of inflammatory bowel disease: a multicenter retrospective study (with video). Gastrointest Endosc. 2024. PMID: 39053652. doi:10.1016/j.gie.2024.07.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。